{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:07:39Z","timestamp":1755598059330,"version":"3.40.5"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.msard.2023.105063","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:50:25Z","timestamp":1697644225000},"page":"105063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-8497","authenticated-orcid":false,"given":"Yuhang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lvli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.105063_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2016.12.009","article-title":"Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis","volume":"12","author":"Baheerathan","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105063_bib0002","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.msard.2019.06.002","article-title":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008\u20122018: a nationwide, population-based cohort study","volume":"33","author":"Boesen","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105063_bib0003","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejpn.2020.10.006","article-title":"E.U. paediatric MOG consortium consensus: part 1\u2014classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders","volume":"29","author":"Bruijstens","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2023.105063_bib0004","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome","volume":"266","author":"Budhram","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2023.105063_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103020","article-title":"Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: a distinct clinical entity?","volume":"52","author":"Chen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.msard.2023.105063_bib0006","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.105063_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2023.105063_bib0008","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/dmcn.13703","article-title":"Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes","volume":"60","author":"Duignan","year":"2018","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.msard.2023.105063_bib0009","doi-asserted-by":"crossref","unstructured":"Duignan, S.M., Hemingway, C.A.J.P., Health, C., 2019. Paediatric acquired demyelinating syndromes. 29(11), 468\u2013475.","DOI":"10.1016\/j.paed.2019.07.010"},{"issue":"2","key":"10.1016\/j.msard.2023.105063_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","article-title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","volume":"20","author":"Fadda","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.105063_bib0011","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.msard.2018.01.007","article-title":"Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis","volume":"20","author":"Fan","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105063_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761354","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective analysis of 35 cases","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2023.105063_bib0013","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.105063_bib0014","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.105063_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102075","article-title":"Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: a case report and review of literature","volume":"42","author":"Gulec","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105063_bib0016","article-title":"Glial fibrillary acidic protein astrocytopathy in pediatric patients: a retrospective study","volume":"8","author":"Huang","year":"2020","journal-title":"Front. Pediatr."},{"issue":"17","key":"10.1016\/j.msard.2023.105063_bib0017","doi-asserted-by":"crossref","first-page":"e1866","DOI":"10.1212\/WNL.0000000000009320","article-title":"Mystery case: anti-NMDAR encephalitis with overlapping demyelinating syndrome","volume":"94","author":"Kim","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105063_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577479","article-title":"Pediatric anti-N-methyl-D-aspartate receptor encephalitis in southern China: analysis of 111 cases","volume":"352","author":"Li","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.105063_bib0019","article-title":"Clinical and prognostic analysis of autoantibody-associated CNS demyelinating disorders in children in Southwest China","volume":"12","author":"Li","year":"2021","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2023.105063_bib0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol."},{"issue":"22","key":"10.1016\/j.msard.2023.105063_bib0021","doi-asserted-by":"crossref","first-page":"e2302","DOI":"10.1212\/WNL.0000000000009239","article-title":"Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies","volume":"94","author":"Martinez-Hernandez","year":"2020","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2023.105063_bib0022","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.25699","article-title":"N-Methyl-D-aspartate receptor antibodies in autoimmune encephalopathy alter oligodendrocyte function","volume":"87","author":"Matute","year":"2020","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2023.105063_bib0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.spen.2017.08.007","article-title":"The spectrum of inflammatory acquired demyelinating syndromes in children","volume":"24","author":"Neuteboom","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.105063_bib0024","doi-asserted-by":"crossref","first-page":"e1052","DOI":"10.1212\/NXI.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"Nosadini","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2023.105063_bib0025","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105063_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577753","article-title":"The changing spectrum of antibody-mediated encephalitis in China","volume":"361","author":"Ren","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.105063_bib0027","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3389\/fneur.2019.01271","article-title":"Co-occurrence of anti-N-methyl-D-Aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: a clinical phenomenon to be taken seriously","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.105063_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.14074","article-title":"Immune reconstitution inflammatory syndrome in non-HIV immunosuppressed patients","volume":"45","author":"Sueki","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.msard.2023.105063_bib0029","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fped.2020.00339","article-title":"Pediatric NMOSD: a review and position statement on approach to work-up and diagnosis","volume":"8","author":"Tenembaum","year":"2020","journal-title":"Front. Pediatr."},{"issue":"3","key":"10.1016\/j.msard.2023.105063_bib0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.105063_bib0031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.105063_bib0032","article-title":"Pediatric anti-N-methyl-D-aspartate receptor encephalitis with MOG-Ab co-existence: relapse propensity and treatability","volume":"58","author":"Weihua","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105063_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.605042","article-title":"Clinical characteristics and prognostic factors of children with anti-N-methyl-D-Aspartate receptor encephalitis","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.msard.2023.105063_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejpn.2021.07.004","article-title":"Age-dependent characteristics and prognostic factors of pediatric anti-N-methyl-D-aspartate receptor encephalitis in a Chinese single-center study","volume":"34","author":"Zhang","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.105063_bib0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/ane.13568","article-title":"Relapse factors of patients of anti-N-methyl-D-aspartate receptor encephalitis","volume":"145","author":"Zhao","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2023.105063_bib0036","article-title":"Relapses of anti-NMDAR, anti-GABABR and anti-LGI1 encephalitis: a retrospective cohort study","volume":"13","author":"Zhong","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823005643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823005643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T01:21:42Z","timestamp":1724894502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823005643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":36,"alternative-id":["S2211034823005643"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.105063","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.105063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105063"}}